{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:06:21Z","timestamp":1758053181555,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RP-2-16-07-001"],"award-info":[{"award-number":["RP-2-16-07-001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009250","name":"National Institute for Social Care and Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King&apos;s College London","doi-asserted-by":"publisher","award":["WT 203148\/Z\/16\/Z"],"award-info":[{"award-number":["WT 203148\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004941","name":"Guy&apos;s and St Thomas&apos; NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.crad.2022.09.124","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T18:33:26Z","timestamp":1667327606000},"page":"e89-e98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The frequency of change in five-point scale score with a Bayesian penalised likelihood PET reconstruction algorithm on interim FDG PET-CT and its potential implications for therapy decisions in Hodgkin's lymphoma"],"prefix":"10.1016","volume":"78","author":[{"given":"M.","family":"Subesinghe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.G.","family":"Mikhaeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.F.","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2022.09.124_bib1","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2022.09.124_bib2","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin\u2019s lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2022.09.124_bib3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/annonc\/mdi200","article-title":"Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin\u2019s lymphoma","volume":"16","author":"Hutchings","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.crad.2022.09.124_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin\u2019s lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.crad.2022.09.124_bib5","first-page":"475","article-title":"The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease","volume":"91","author":"Gallamini","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.crad.2022.09.124_bib6","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2022.09.124_bib7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2967\/jnumed.109.073197","article-title":"18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin\u2019s lymphoma","volume":"51","author":"Cerci","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2022.09.124_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00259-011-1916-8","article-title":"Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients","volume":"39","author":"Zinzani","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib9","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2022.09.124_bib10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/lYSA\/FIL H10 trial","volume":"35","author":"Andre","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2022.09.124_bib11","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2022.09.124_bib12","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2022.09.124_bib13","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1182\/blood.2019000719","article-title":"Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III\/IV Hodgkin\u2019s lymphoma","volume":"134","author":"Stephens","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.crad.2022.09.124_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bjh.18083","article-title":"Guideline for the first-line management of classical Hodgkin lymphoma\u2014a British Society for Haematology guideline","volume":"197","author":"Follows","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.crad.2022.09.124_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.6004\/jnccn.2022.0021","article-title":"NCCN Guidelines\u00ae insights: Hodgkin lymphoma, version 2.2022","volume":"20","author":"Hoppe","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.crad.2022.09.124_bib16","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","article-title":"Hodgkin\u2019s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Eichenauer","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.crad.2022.09.124_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.112.110890","article-title":"International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers","volume":"54","author":"Biggi","year":"2013","journal-title":"J Nucl Med"},{"year":"2014","series-title":"White paper: Q.Clear","key":"10.1016\/j.crad.2022.09.124_bib18"},{"key":"10.1016\/j.crad.2022.09.124_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13550-020-00690-6","article-title":"Impact of the Q.Clear reconstruction algorithm on the interpretation of PET\/CT images in patients with lymphoma","volume":"10","author":"Wyrzykowski","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.crad.2022.09.124_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-019-0536-3","article-title":"The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations","volume":"9","author":"Ly","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.crad.2022.09.124_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MNM.0000000000001516","article-title":"Effect of Bayesian penalty likelihood algorithm on 18F-FDG PET\/CT image of lymphoma","volume":"43","author":"Wang","year":"2022","journal-title":"Nucl Med Comm"},{"key":"10.1016\/j.crad.2022.09.124_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00259-017-3893-z","article-title":"All that glitters is not gold\u2014new reconstruction methods using Deauville criteria for patient reporting","volume":"45","author":"Barrington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2967\/jnumed.117.202721","article-title":"Does PET reconstruction method affect Deauville score in lymphoma patients?","volume":"59","author":"Enilorac","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2022.09.124_bib24","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2967\/jnumed.115.159301","article-title":"Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET\/CT system","volume":"56","author":"Teoh","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2022.09.124_bib25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00330-015-3832-y","article-title":"Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules","volume":"26","author":"Teoh","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2022.09.124_bib26","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1007\/s00330-016-4253-2","article-title":"18F-FDG PET\/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction","volume":"26","author":"Teoh","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2022.09.124_bib27","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.ejrad.2015.06.025","article-title":"Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?","volume":"84","author":"Parvizi","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.crad.2022.09.124_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejrad.2019.06.005","article-title":"The effect of a novel Bayesian penalised likelihood PET reconstruction algorithm on the assessment of malignancy risk in solitary pulmonary nodules according to the British Thoracic Society guidelines","volume":"117","author":"Murphy","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.crad.2022.09.124_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","article-title":"FDG PET for therapy monitoring in Hodgkin and non-Hodgkin\u2019s lymphomas","volume":"44","author":"Barrington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.crad.2022.09.124_bib31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s12149-017-1192-1","article-title":"Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET\/CT","volume":"31","author":"Howard","year":"2017","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.crad.2022.09.124_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmp.2018.02.013","article-title":"Bayesian penalized-likelihood reconstruction algorithm suppresses edge artifacts in PET reconstruction based on point-spread-function","volume":"47","author":"Yamaguchi","year":"2018","journal-title":"Phys Med"},{"key":"10.1016\/j.crad.2022.09.124_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00259-017-3727-z","article-title":"Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET","volume":"44","author":"van der Vos","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s13139-019-00594-x","article-title":"How do the more recent reconstruction algorithms affect the interpretation criteria of PET\/CT images?","volume":"53","author":"Matti","year":"2019","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00259-015-3165-8","article-title":"Impact of PET\/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis","volume":"43","author":"Kuhnert","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","article-title":"EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies","volume":"44","author":"Aide","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib37","first-page":"CD007941","article-title":"Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin\u2019s lymphoma","volume":"2017","author":"Skoetz","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.crad.2022.09.124_bib38","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1007\/s00259-021-05403-2","article-title":"Moving the goalposts while scoring\u2014the dilemma posed by new PET technologies","volume":"48","author":"Rogasch","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2022.09.124_bib39","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00259-018-3977-4","article-title":"Feasibility of state of the art PET\/CT systems performance harmonisation","volume":"45","author":"Kaalep","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926022006699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926022006699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:47:22Z","timestamp":1757868442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926022006699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0009926022006699"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2022.09.124","relation":{},"ISSN":["0009-9260"],"issn-type":[{"type":"print","value":"0009-9260"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The frequency of change in five-point scale score with a Bayesian penalised likelihood PET reconstruction algorithm on interim FDG PET-CT and its potential implications for therapy decisions in Hodgkin's lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2022.09.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}